Peer-reviewed veterinary case report
Topical hydrocortisone spray cuts itching in dogs with flea allergy
By Bonneau, S et al.·Published in Australian veterinary journal·2009·R&D Department, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea-allergy dermatitis in dogs.
- Species:
- dog
Plain-English summary
A group of 16 beagles with flea-allergy dermatitis (FAD) were treated with a topical spray containing hydrocortisone aceponate (HCA) to see how well it could relieve their itching and skin problems. After just two days, the dogs receiving the HCA spray had a 94% reduction in itching, while the dogs not receiving treatment showed only a 24% reduction. By the end of the week, the dogs treated with HCA also had significant improvements in their skin lesions compared to the untreated group, with no side effects reported. This suggests that HCA is an effective option for managing itching and skin issues related to flea allergies in dogs.
People also search for: dog flea allergy treatment · hydrocortisone for dog itching · how to relieve dog skin problems
Abstract
OBJECTIVE: To evaluate the treatment efficacy of a topical spray containing hydrocortisone aceponate (HCA) on dogs with flea-allergy dermatitis (FAD). DESIGN: A controlled clinical study was conducted on dogs with experimentally induced FAD. Sixteen laboratory beagles with mild to moderate clinical signs were divided into two groups. The test group received HCA by topical spray once daily for 7 days, while the control group did not. Pruritic events (time and frequency) were videotaped and then scored. Clinical signs (erythema, papules, excoriation and alopecia) present on four anatomical regions were monitored and their severity directly assessed. RESULTS: After 2 days, pruritus was reduced by 94% in the treatment group and by 24% in the control group (P = 0.014) in cumulative time, and by 86% versus 34% (P = 0.034) in frequency. The HCA spray also resulted in significant improvements in overall clinical signs: 23% versus 0% in the control group (P = 0.0006) on day 3 and 43% versus 15% in the control group (P = 0.0006) on day 7. During the 7-day trial, no drug-related adverse effects were observed. CONCLUSIONS: Topical treatment with HCA showed a rapid and potent antipruritic effect on dogs with FAD. HCA also demonstrated significant overall therapeutic effects on FAD-associated skin lesions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19573156/